AGALLOCO & ASSOCIATES 2022 TRAINING OFFERINGS
7 June 2022
Quality and expertise certified for Fedegari Group: EN ISO 3834-2 and AD 2000-HP0
5 July 2022Fedegari Group @ Interphex 2022
From May 24-26th, Fedegari showcased its outstanding process solutions in the most important pharmaceutical, biotechnology and medical device development and manufacturing event in New York City.
Weren’t you able to join us in New York?
During the event, Fedegari had the opportunity to get in touch with pharma professionals and partners to discuss ways in improving customers’ performances through our innovative process approach in sterile drug manufacturing.
Many visitors stopped by the Fedegari booth and had the possibility to evaluate the company capabilities including a full line of life science products and solutions. It was an opportunity to discuss robotized projects that will drive the future of the pharmaceutical industry.
In addition, Fedegari presented to visitors its recent US Tech Center expansion and new training courses that will be held in 2022 in the brand-new facilities in collaboration with PDA and Jim Agalloco.
Returning for the first time since 2019, Fedegari was pleased to be an exhibitor at Interphex NY. The event leveraged Fedegari’s work in knowledge sharing while connecting with pharma experts and industry peers, and also learning new experiences and market needs that can enhance products and services leading to cost-effective process solutions for customers.
There was an energetic feeling set from the start of Interphex and our premiere customers and in-booth gatherings helped carried this tone throughout the entirety of the show.
We look forward to the future opportunities in helping advance your performance.
Let’s identify innovative solutions to improve your processes together!
See the event gallery!
If you weren’t able to join us in New York…
Schedule a visit at our Tech Center!
We welcome all our esteemed customers to benefit
from technical support, training, and R&D personnel expertise on process and cycle development.